Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)
USD 1.27
(0.0%)
USD 1.27
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 260.29 Billion CNY | 12.21% |
| 2022 | 231.98 Billion CNY | 7.49% |
| 2021 | 215.82 Billion CNY | 12.46% |
| 2020 | 191.9 Billion CNY | 2.86% |
| 2019 | 186.56 Billion CNY | 17.27% |
| 2018 | 159.08 Billion CNY | 21.58% |
| 2017 | 130.84 Billion CNY | 8.35% |
| 2016 | 120.76 Billion CNY | 14.45% |
| 2015 | 105.51 Billion CNY | 14.2% |
| 2014 | 92.39 Billion CNY | 18.12% |
| 2013 | 78.22 Billion CNY | 14.9% |
| 2012 | 68.07 Billion CNY | 24.0% |
| 2011 | 54.89 Billion CNY | 46.75% |
| 2010 | 37.41 Billion CNY | 91.18% |
| 2009 | 19.56 Billion CNY | 18.25% |
| 2008 | 16.54 Billion CNY | 18.88% |
| 2007 | 13.91 Billion CNY | 21.99% |
| 2006 | 11.41 Billion CNY | 6.64% |
| 2005 | 10.69 Billion CNY | -1.07% |
| 2004 | 10.81 Billion CNY | 10.52% |
| 2003 | 9.78 Billion CNY | 35.24% |
| 2002 | 7.23 Billion CNY | 39.09% |
| 2001 | 5.2 Billion CNY | 13.2% |
| 2000 | 4.59 Billion CNY | 1.44% |
| 1999 | 4.52 Billion CNY | 2.64% |
| 1998 | 4.41 Billion CNY | 1198.77% |
| 1997 | 339.81 Million CNY | 5.87% |
| 1996 | 320.96 Million CNY | -4.86% |
| 1995 | 337.35 Million CNY | 39.84% |
| 1994 | 241.25 Million CNY | 6.89% |
| 1993 | 225.7 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 69.06 Billion CNY | -1.25% |
| 2024 Q3 | 70.21 Billion CNY | 1.66% |
| 2024 Q1 | 69.94 Billion CNY | 11.4% |
| 2023 FY | 260.29 Billion CNY | 12.21% |
| 2023 Q1 | 66.22 Billion CNY | 15.44% |
| 2023 Q3 | 64.91 Billion CNY | -2.18% |
| 2023 Q2 | 66.36 Billion CNY | 0.21% |
| 2023 Q4 | 62.78 Billion CNY | -3.28% |
| 2022 FY | 231.98 Billion CNY | 7.49% |
| 2022 Q4 | 57.36 Billion CNY | -8.8% |
| 2022 Q3 | 62.9 Billion CNY | 14.77% |
| 2022 Q2 | 54.8 Billion CNY | -3.67% |
| 2022 Q1 | 56.89 Billion CNY | 3.73% |
| 2021 Q4 | 54.85 Billion CNY | -1.59% |
| 2021 Q3 | 55.73 Billion CNY | 3.91% |
| 2021 FY | 215.82 Billion CNY | 12.46% |
| 2021 Q1 | 51.59 Billion CNY | 0.03% |
| 2021 Q2 | 53.63 Billion CNY | 3.95% |
| 2020 Q3 | 53.15 Billion CNY | 13.79% |
| 2020 FY | 191.9 Billion CNY | 2.86% |
| 2020 Q1 | 40.44 Billion CNY | -11.97% |
| 2020 Q2 | 46.71 Billion CNY | 15.5% |
| 2020 Q4 | 51.58 Billion CNY | -2.95% |
| 2019 Q2 | 46.56 Billion CNY | 1.22% |
| 2019 FY | 186.56 Billion CNY | 17.27% |
| 2019 Q1 | 46 Billion CNY | 10.91% |
| 2019 Q3 | 48.04 Billion CNY | 3.16% |
| 2019 Q4 | 45.94 Billion CNY | -4.36% |
| 2018 FY | 159.08 Billion CNY | 21.58% |
| 2018 Q2 | 39.49 Billion CNY | 8.54% |
| 2018 Q3 | 41.72 Billion CNY | 5.65% |
| 2018 Q1 | 36.38 Billion CNY | 14.37% |
| 2018 Q4 | 41.48 Billion CNY | -0.58% |
| 2017 Q4 | 31.81 Billion CNY | -4.32% |
| 2017 Q3 | 33.25 Billion CNY | 1.85% |
| 2017 FY | 130.84 Billion CNY | 8.35% |
| 2017 Q1 | 33.12 Billion CNY | 9.53% |
| 2017 Q2 | 32.64 Billion CNY | -1.45% |
| 2016 Q4 | 30.24 Billion CNY | -1.86% |
| 2016 FY | 120.76 Billion CNY | 14.45% |
| 2016 Q1 | 29.27 Billion CNY | 10.57% |
| 2016 Q2 | 30.41 Billion CNY | 3.91% |
| 2016 Q3 | 30.82 Billion CNY | 1.32% |
| 2015 Q4 | 26.47 Billion CNY | -5.75% |
| 2015 FY | 105.51 Billion CNY | 14.2% |
| 2015 Q3 | 28.09 Billion CNY | 8.77% |
| 2015 Q1 | 25.12 Billion CNY | 6.09% |
| 2015 Q2 | 25.82 Billion CNY | 2.79% |
| 2014 Q1 | 21.27 Billion CNY | 5.5% |
| 2014 FY | 92.39 Billion CNY | 18.12% |
| 2014 Q4 | 23.68 Billion CNY | -4.13% |
| 2014 Q3 | 24.7 Billion CNY | 8.64% |
| 2014 Q2 | 22.73 Billion CNY | 6.89% |
| 2013 FY | 78.22 Billion CNY | 14.9% |
| 2013 Q1 | 19.59 Billion CNY | 15.71% |
| 2013 Q2 | 19.12 Billion CNY | -2.36% |
| 2013 Q4 | 20.16 Billion CNY | 4.27% |
| 2013 Q3 | 19.33 Billion CNY | 1.11% |
| 2012 FY | 68.07 Billion CNY | 24.0% |
| 2012 Q4 | 16.93 Billion CNY | -3.4% |
| 2012 Q2 | 16.96 Billion CNY | 1.84% |
| 2012 Q1 | 16.65 Billion CNY | 13.85% |
| 2012 Q3 | 17.52 Billion CNY | 3.32% |
| 2011 Q1 | 11.86 Billion CNY | 24.69% |
| 2011 Q2 | 13.34 Billion CNY | 12.42% |
| 2011 Q3 | 14.37 Billion CNY | 7.75% |
| 2011 Q4 | 14.63 Billion CNY | 1.77% |
| 2011 FY | 54.89 Billion CNY | 46.75% |
| 2010 Q1 | 9.49 Billion CNY | 98.11% |
| 2010 FY | 37.41 Billion CNY | 91.18% |
| 2010 Q2 | 9.02 Billion CNY | -4.98% |
| 2010 Q3 | 9.37 Billion CNY | 3.83% |
| 2010 Q4 | 9.51 Billion CNY | 1.58% |
| 2009 FY | 19.56 Billion CNY | 18.25% |
| 2009 Q4 | 4.79 Billion CNY | -9.33% |
| 2009 Q3 | 5.28 Billion CNY | 11.0% |
| 2009 Q2 | 4.76 Billion CNY | 0.86% |
| 2009 Q1 | 4.72 Billion CNY | 9.32% |
| 2008 Q3 | 4.38 Billion CNY | 15.68% |
| 2008 Q1 | 4.05 Billion CNY | -4.01% |
| 2008 FY | 16.54 Billion CNY | 18.88% |
| 2008 Q2 | 3.79 Billion CNY | -6.47% |
| 2008 Q4 | 4.32 Billion CNY | -1.48% |
| 2007 Q4 | 4.22 Billion CNY | 24.83% |
| 2007 Q3 | 3.38 Billion CNY | 5.99% |
| 2007 Q2 | 3.19 Billion CNY | 2.12% |
| 2007 FY | 13.91 Billion CNY | 21.99% |
| 2007 Q1 | 3.12 Billion CNY | 8.97% |
| 2006 Q4 | 2.86 Billion CNY | 1.67% |
| 2006 FY | 11.41 Billion CNY | 6.64% |
| 2006 Q1 | 3.06 Billion CNY | 113.8% |
| 2006 Q2 | 2.66 Billion CNY | -13.02% |
| 2006 Q3 | 2.82 Billion CNY | 5.97% |
| 2005 Q4 | 1.43 Billion CNY | -55.29% |
| 2005 FY | 10.69 Billion CNY | -1.07% |
| 2005 Q1 | 3.19 Billion CNY | 18.35% |
| 2005 Q3 | 3.2 Billion CNY | 11.38% |
| 2005 Q2 | 2.87 Billion CNY | -9.93% |
| 2004 FY | 10.81 Billion CNY | 10.52% |
| 2004 Q4 | 2.69 Billion CNY | 5.84% |
| 2004 Q1 | 2.93 Billion CNY | -10.76% |
| 2004 Q2 | 2.64 Billion CNY | -9.88% |
| 2004 Q3 | 2.54 Billion CNY | -3.52% |
| 2003 Q3 | 2.13 Billion CNY | -7.12% |
| 2003 FY | 9.78 Billion CNY | 35.24% |
| 2003 Q4 | 3.28 Billion CNY | 53.67% |
| 2003 Q2 | 2.3 Billion CNY | 11.39% |
| 2003 Q1 | 2.06 Billion CNY | 8.48% |
| 2002 Q3 | 1.85 Billion CNY | 7.57% |
| 2002 FY | 7.23 Billion CNY | 39.09% |
| 2002 Q1 | 1.74 Billion CNY | 0.0% |
| 2002 Q4 | 1.9 Billion CNY | 2.42% |
| 2002 Q2 | 1.72 Billion CNY | -0.95% |
| 2001 FY | 5.2 Billion CNY | 13.2% |
| 2000 FY | 4.59 Billion CNY | 1.44% |
| 1999 FY | 4.52 Billion CNY | 2.64% |
| 1998 FY | 4.41 Billion CNY | 1198.77% |
| 1997 FY | 339.81 Million CNY | 5.87% |
| 1996 FY | 320.96 Million CNY | -4.86% |
| 1995 FY | 337.35 Million CNY | 39.84% |
| 1994 FY | 241.25 Million CNY | 6.89% |
| 1993 FY | 225.7 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| China Medicine Corporation | 64.75 Million USD | -401893.817% |
| DH Enchantment Inc. | 686.00 USD | -37943890416.472% |
| Exlites Holdings International, Inc. | 18.74 Thousand USD | -1388981164.37% |
| Itonis, Inc. | 1801.00 USD | -14452808836.313% |
| One Step Vending Corp. | - USD | -Infinity% |
| MediPal Holdings Corporation | 23.51 Billion USD | -1007.048% |
| PD-Rx Pharmaceuticals, Inc. | 21.27 Million USD | -1223573.431% |
| Pharmagen, Inc. | 4813.05 USD | -5408110951.059% |
| Suzuken Co., Ltd. | 15.76 Billion USD | -1550.827% |